Achieve Superior Results today for Your Depression with Spravato Nasal Spray
The STAR*D trial demonstrated that the more antidepressants a patient trial’s the less likely they are to respond overall. By the point a patient tries 3 antidepressant’s, the remission rate is only about 15% with another treatment trial. Of the patients who respond remit at level 3 of 4, 60-70% will relapse within 6 months.
